BRIEF — Zydus Lifesciences Says FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted For Review By USFDA
Oct 13 (Reuters) — Zydus Lifesciences Ltd: Fyb206 Becomes First Publicly Announced Keytruda Biosimilar Accepted For Review By Usfda Further company coverage: ZYDU.NS (Reuters.Briefs@thomsonreuters.com;;)